Medically reviewed by Archana Sharma, DO Diagnosing multiple myeloma, also referred to as myeloma, is often a complex process ...

While the introduction of novel therapies has led to substantial improvements in the outcomes of patients with newly ...

The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is ...

Multiple myeloma is a disease characterized by the proliferation of plasma cells which can lead to the abnormally high production of monoclonal immunoglobulins, detected in serum and urine.

When you get a diagnosis of multiple myeloma, you may not even know what it is. Find out why this type of cancer is different from most others and what your treatment options look like.

Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.

Multiple myeloma has long been a killer. Therapies are changing that. New drugs have made it possible to live much longer with the disease, and some scientists even see a possible cure down the road ...

The novel criteria for the diagnosis of symptomatic multiple myeloma have revealed the value of modern imaging for the management of patients with myeloma. Whole-body low-dose CT (LDCT) has increased ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and miraculously beating the odds.

Learn about the importance of early multiple myeloma treatment and access to clinical trials for Black people with this form of blood cancer.

Belantamab Mafodotin in Multiple Myeloma Results A total of 302 patients underwent randomization; 155 were assigned to the BPd group, and 147 to the PVd group.